Importance of Urologic Evaluation in Staging Gynecologic Carcinoma.
- Author:
Do Whan AHN
1
;
Sung Choon LEE
Author Information
1. Department of Urology, Presbyterian Medical Center, College of Medicine, Keimyung University, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
gynecologic carcinoma;
staging
- MeSH:
Adenocarcinoma;
Biopsy;
Choriocarcinoma;
Cystoscopy;
Daegu;
Female;
Humans;
Korea;
Leiomyosarcoma;
Male;
Pregnancy;
Protestantism;
Urinary Bladder;
Urology;
Uterus
- From:Korean Journal of Urology
1980;21(6):592-595
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A clinical observation was male on 1,366 patients of gynecologic carcinoma with I.V.P., cystoscopy and T U.R. bladder biopsy at the Department of Urology, Presbyterian Medical Center, Keimyung University School of Medicine, Daegu, Korea during the period from September 1970 through December 1979. The results were as follows: 1. The most common gynecologic carcinomas were cervical carcinoma, adenocarcinoma (endocervical and endometrial), vaginal carcinoma, ovarian carcinoma, vulvar carcinoma, choriocarcinoma and leiomyosarcoma uteri. 2. Of gynecologic carcinoma patients, abnormal I.V.P. findings were noted in 12.96%, abnormal cystoscopic findings in 7.39% and T.U.R. bladder biopsy was done in 2.64% with positive findings in 47.22%. 3. Of cervical carcinoma, it was classified as follows : stage II b (33.81%). stage II a (30.96%), stage III b(16.07%), stage IV(13.O6%), stage IV(33.33%). stage III a(1.66%) and stage la(1.11%) in order. 4. Of cervical carcinoma, abnormal I.V.P findings were noted in 12.5%(stage I-1. 12%, stage II-5. 99%, stage III-34.82%, stage lV-71.43%) with abnormal cystoscopic findings in 6.8%(stage I-1. 12t, stage II-2. 20%, stage III-17. 89%. stage lV_64.29%). 5. Of cervical carcinoma, T.U.R. bladder biopsy was done in 9 cases of II b with 6 positive fin dings, 14 cases of III b with 4 positive findings and 5 cases of IV with 4 positive findings of gynecologic carcinoma. Therefore, it is emphasized that urologic evaluation including I.V.P. and cystoscopy should be per formed in all gynecologic carcinoma patients before treatment.
